Junjie Shen

3.5k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Junjie Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junjie Shen has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Junjie Shen's work include RNA modifications and cancer (8 papers), CAR-T cell therapy research (8 papers) and Cancer Cells and Metastasis (7 papers). Junjie Shen is often cited by papers focused on RNA modifications and cancer (8 papers), CAR-T cell therapy research (8 papers) and Cancer Cells and Metastasis (7 papers). Junjie Shen collaborates with scholars based in China, Spain and United States. Junjie Shen's co-authors include Cheng Qian, Juanjuan Shan, Zhi Yang, Yanmin Xu, Leina Ma, Xiu‐Wu Bian, Limei Liu, Chungang Liu, Yimin Chai and You‐Hong Cui and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Junjie Shen

61 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bispecific Antibodies: From Research to Clinical Application

2021 220 citations Junjie Shen, Yanan Qi et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Junjie Shen

Since Specialization

Citations

This map shows the geographic impact of Junjie Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Shen more than expected).

Fields of papers citing papers by Junjie Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Shen. The network helps show where Junjie Shen may publish in the future.

Co-authorship network of co-authors of Junjie Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Shen. A scholar is included among the top collaborators of Junjie Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Shen. Junjie Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	M2 Macrophage‐Extracellular Vesicle‐Derived lncRNA‐NEAT1 Regulates miR‐204‐5p/RRS1‐mediated Cell Cycle to Promote the Occurrence and Development of Colorectal Cancer	Journal of Biochemical and Molecular Toxicology	Junjie Shen et al.	0
2	Mechano-bioactive hydrogel bioelectronics for mechanical-electrical-bioenergetic conversion and glia-modulating neural regeneration	Nature Communications	Junjie Shen, Shihao Wu et al.	0
3	Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells	Autoimmunity Reviews	Xue He, Bin Hu et al.	18
4	Development and preliminary validation of a PROS scale for Chinese bladder cancer patients with abdominal stoma	Scientific Reports	Hui Hong, Yonghui Zhang et al.	1
5	Long non-coding RNA GATA6-AS1 is mediated by N6-methyladenosine methylation and inhibits the proliferation and metastasis of gastric cancer	World Journal of Gastrointestinal Oncology	Junjie Shen, Wen-Ming Chen et al.	2
6	Tissue mechanics modulate PCNP expression in oral squamous cell carcinomas with different differentiation	Frontiers in Oncology	Leyang Zhang, Junjie Shen et al.	1
7	SH-BAW devices with abnormal mass-loading effect for chemical sensing	Applied Physics Letters	Junjie Shen, Peng Li et al.	0
8	Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study	Cytotherapy	Jun Chen, Yongchun Zhao et al.	8
9	Baicalein facilitates gastric cancer cell apoptosis by triggering endoplasmic reticulum stress via repression of the PI3K/AKT pathway	Applied Biological Chemistry	Junjie Shen, Zhiwen Yang et al.	14
10	Biomimetic hydrogel derived from decellularized dermal matrix facilitates skin wounds healing	Materials Today Bio	Yaling Yu, Huimin Xiao et al.	25
11	Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials	Frontiers in Cardiovascular Medicine	Gong Chen, Ke Zhang et al.	10
12	Bispecific Antibodies: From Research to Clinical Application breakdown →	Frontiers in Immunology	Junjie Shen, Yanan Qi et al.	220
13	Deacetylation of β-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cells	Cancer Letters	Xuejiao Chen, Hong-Bo Huan et al.	37
14	MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer	Cancer Research	Li Su, Yongli Luo et al.	57
15	SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression	Cancer Letters	Feifei Cheng, Li Su et al.	84
16	RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells	Cell Death and Disease	Yongxin Yang, Haineng Xu et al.	23
17	MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways	Cancer Letters	Yanmin Xu, Leina Ma et al.	135
18	Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes	Cancer Research	Leina Ma, Jia Liu et al.	74
19	Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells	Cancer Biology & Therapy	Yan Xu, Dan Wang et al.	10
20	Clinical Study of Transarterial Chemotherapy in Combination with Iodine-125 Seed Implantation in Treating the Advanced Pancreatic Carcinoma		Junjie Shen, Yonghui Huang et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact